发明名称 |
Pharmaceutical compositions comprising mannose binding lectin |
摘要 |
The present invention relates to pharmaceutical compositions comprising MBL and/or MBL variants. In particular the invention relates to pharmaceutical compositions comprising at least 200 mu g/ml protein containing material, wherein mannan binding lectin (MBL) and/or MBL variants constitutes at least 35% (w/w) of the total protein; or to compositions comprising at least 400 mu g/ml mannan binding lectin (MBL) and/or MBL variants. In addition the invention relates to pharmaceutical compositions comprising MBL and/or MBL variants and divalent cations. The invention also describes methods of preparing said compositions. <??>The pharmaceutical compositions according to the invention may for example be used in methods of treatment of a number of different clinical conditions including infections. Uses of the compositions for preparation of medicaments for treatment of a clinical condition are also described.
|
申请公布号 |
EP1344533(A1) |
申请公布日期 |
2003.09.17 |
申请号 |
EP20030388016 |
申请日期 |
2003.03.14 |
申请人 |
NATIMMUNE A/S |
发明人 |
LARSEN, JESPER LUND;KONGERSLEV, LEIF |
分类号 |
A61K9/08;A61K9/10;A61K35/16;A61K38/00;A61K38/17;A61K38/48;A61K47/04;A61K47/12;A61K47/18;A61K47/22;A61K47/24;A61K47/26;A61K47/34;A61K47/36;A61K47/42;A61P31/00;A61P31/04;A61P31/10;A61P31/12;(IPC1-7):A61K38/17 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|